PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives
Frontiers in Pharmacology · 28.10.2025 · 16
DOI: 10.3389/fphar.2025.1714460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.10.2025. Verfasst von Yuhan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Zigong Fourth People's Hospital, Zigong, Sichuan, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a leading cause of cancer mortality, and the benefits of immune checkpoint inhibitors are largely confined to the dMMR/MSI-H minority, underscoring the need to remodel the immunosuppressive tumor microenvironment (TME). Poly (lactic-co-glycolic acid) (PLGA) nanoparticles offer biodegradable, tunable carriers with high payload capacity and amenability to targeting, enabling precise delivery and controlled release of immunomodulators. In CRC, these platforms can enhance antigen capture and presentation, recondition suppressive myeloid networks, and coordinate checkpoint blockade with complementary therapeutics to strengthen antitumor immunity and restrain tumor growth. In this review, we summarize current principles for PLGA nanoparticles-based immunotherapies, emphasizing payload selection, release kinetics, microenvironmental responsiveness, and spatiotemporal targeting in CRC. We also outline translational considerations encompassing safety, pharmacokinetics, manufacturability, and regulatory readiness. Addressing these factors may accelerate clinical deployment of PLGA-enabled strategies and extend the benefits of immunotherapy in CRC patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Zigong Fourth People's Hospital, Zigong, Sichuan, China.
- Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Wang, Y., Huang, P., Li, C., Tu, S., & Yang, H. (2025). PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1714460
Vancouver
Wang Y, Huang P, Li C, Tu S, Yang H. PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1714460
BibTeX
@article{Wang2025,
author = {Wang, Yuhan and Huang, Peng and Li, Chun and Tu, Shengjin and Yang, Hua},
title = {PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1714460}
}
EUVIMED